Produkte mit Hanf - Was Kapseln und Öle mit CBD taugen

Neuropsychopharmacology. 2011 May; 36( 6 ):1219 -26 Morgan CJ, Freeman TP, Schafer GL, Curran HV. Cannabidiol attenuates the appetitive results of Delta 9-tetrahydrocannabinol in people smoking their selected marijuana. This Site ( 9 ):1879 -85 Carlini EA, Cunha JM. Hypnotic and antiepileptic impacts of cannabidiol. J Clin Pharmacol. 1981 Aug-Sep; 21(8-9 Suppl):417 S-427S Irving PM, Iqbal T, Nwokolo C, Subramanian S, Flower S, Prasad N, Hart A, Murray C, Lindsay JO, Taylor A, Barron R, Wright S.

Inflamm Bowel Dis. 2018 Mar 19; 24( 4 ):714 -724 [20,1] Cuetti L, Manzo L, Peyraube R, Arnaiz J, Curi L, Orihuela S. Chronic Discomfort, Treatment With Cannabidiol in Kidney Transplant Clients in Uruguay. Transplant, Proc. 2018 Mar; 50( 2 ):461 -464. Naftali T, Bar-Lev Schleider L, Dotan I, Lansky EP, Sklerovsky Benjaminov F, Konikoff FM. Marijuana causes a scientific reaction in patients with Crohn's disease: a prospective placebo-controlled study.

2013 Oct; 11( 10 ):1276 -1280 Lynch ME, Cesar-Rittenberg P, Hohmann AG. A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain. J Discomfort Symptom Manage. 2014 Jan; 47( 1 ):166 -73 Serpell M, Ratcliffe S, Hovorka J, Schofield M, Taylor L, Lauder H, Ehler E. A double-blind, randomized, placebo-controlled, parallel group research study of THC/CBD spray in peripheral neuropathic pain treatment.

2014 Aug; 18( 7 ):999 -1012 Leocani L, Nuara A, Houdayer E, Schiavetti I, Del Carro U, Amadio S, Straffi L, Rossi P, Martinelli V, Vila C, Sormani MP, Comi G. Sativex() and clinical-neurophysiological steps of spasticity in progressive numerous sclerosis. J Neurol. 2015 Nov; 262( 11 ):2520 -7 Langford RM, Mares J, Novotna A, Vachova M, Novakova I, Notcutt W, Ratcliffe S.

J Neurol. 2013 Apr; 260( 4 ):984 -97 Serpell MG, Notcutt W, Collin C. Sativex long-term usage: an open-label trial in clients with spasticity due to multiple sclerosis. J Neurol. 2013 Jan; 260( 1 ):285 -95 [26,1] Contin M, Mancinelli L, Perrone A, Sabattini L, Mohamed S, Scandellari C, Foschi M, Vacchiano V, Lugaresi A, Riva R. Tetrahydrocannabinol/Cannabidiol, Oromucosal Spray in Patients With Several Sclerosis: A Pilot Research Study on the Plasma, Concentration-Effect Relationship.